Published in Cardiovasc Drugs Ther on April 01, 1994
Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol Sci (1989) 4.41
Pharmacological actions of the antihypertensive agent N-amidino-2-(2,6-dichlorophenyl)acetamide hydrochloride (BS 100-141). Arzneimittelforschung (1975) 2.72
The effect of indomethacin on the release of prostaglandin E2 and acetylcholine from guinea-pig isolated ileum at rest and during field stimulation. Br J Pharmacol (1974) 2.04
Reductive cleavage of cystine disulfides with tributylphosphine. Methods Enzymol (1977) 1.68
A human cellular model for studying the regulation of glucagon-like peptide-1 secretion. Endocrinology (2001) 1.56
DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory properties. Naunyn Schmiedebergs Arch Pharmacol (1985) 1.50
Stereoselectivity at the calcium channel: opposite action of the enantiomers of a 1,4-dihydropyridine. J Cardiovasc Pharmacol (1985) 1.49
Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem. Br J Pharmacol (1983) 1.48
Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915. J Cardiovasc Pharmacol (1988) 1.40
Modification of vasopressin- and angiotensin II- induced changes by calcium antagonists in the peripheral circulation of anaesthetized rabbits. Br J Pharmacol (1985) 1.35
Human lymphoblastoid interferon. Large scale production and partial purification. J Biol Chem (1977) 1.24
Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. J Clin Oncol (1997) 1.20
PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta. J Cardiovasc Pharmacol (1984) 1.19
A rapid and sensitive assay for arginase. Anal Biochem (1980) 1.13
Effects of the new calcium antagonist PN 200-110 on the myocardium and the regional peripheral circulation in anesthetized cats and dogs. J Cardiovasc Pharmacol (1984) 1.11
Cardiovascular effects of apamin and BRL 34915 in rats and rabbits. Br J Pharmacol (1988) 1.06
Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress. Br J Pharmacol (1996) 1.05
The effect of ergotamine on humoral and neuronal actions in the nictitating membrane and the spleen of the cat. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 1.04
Vasopressin induced production of inositol trisphosphate and calcium efflux in a smooth muscle cell line. Biochem Biophys Res Commun (1985) 1.03
Effect of PY 108-068, a new calcium antagonist, on general hemodynamics and regional blood flow in anesthetized cats: a comparison with nifedipine. J Cardiovasc Pharmacol (1982) 1.01
Trapping and intramyocardial distribution of microspheres with different diameters in cat and rabbit hearts in vitro. Basic Res Cardiol (1982) 0.99
Lack of evidence for voltage dependent calcium channels on platelets. Biochem Biophys Res Commun (1985) 0.97
Solubilization of an active opiate receptor from Bufo marinus. Eur J Pharmacol (1980) 0.97
[Comparative studies on the influencing of adrenergic reactions by ergotamine and dihydroergotamine in different experimental models]. Helv Physiol Pharmacol Acta (1968) 0.96
Assessing calcium antagonism on vascular smooth muscle: a comparison of three methods. J Pharmacol Methods (1983) 0.96
Ergotamine-induced constriction of cranial arteriovenous anastomoses in dogs pretreated with phentolamine and pizotifen. Cephalalgia (1983) 0.95
FTY720: dissection of membrane receptor-operated, stereospecific effects on cell migration from receptor-independent antiproliferative and apoptotic effects. Transplant Proc (2001) 0.95
Effects of the calcium antagonist PY 108-068 on myocardial tissues in vitro and on reflex tachycardia in vivo. J Cardiovasc Pharmacol (1983) 0.94
Studies on the mechanism of action of the vasoconstrictive dihydropyridine, CGP 28392. Eur J Pharmacol (1984) 0.93
Inhibitory effects of clonidine and BS 100-141 on responses to sympathetic nerve stimulation in cats and rabbits. Br J Pharmacol (1975) 0.93
Growth of dissociated neurons in culture dishes coated with synthetic polymeric amines. Neurosci Lett (1984) 0.93
Mechanism of the vasodilator effects of the cardiotonic agent DPI 201-106. J Cardiovasc Pharmacol (1986) 0.92
Validation studies for the use of the microsphere method in cats and young minipigs. Basic Res Cardiol (1981) 0.92
Inhibition of the re-uptake of neuronally liberated noradrenaline and alpha-receptor blocking action of some ergot alkaloids. Br J Pharmacol (1970) 0.91
Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: possible lack of relationship to immunosuppressive activity. Br J Pharmacol (1996) 0.91
Calcium influx inhibition by steroids and analogs in C2C12 skeletal muscle cells. Br J Pharmacol (1998) 0.90
Comparison of cardiodepressant and vasodilator effects of PN 200-110 (isradipine), nifedipine and diltiazem in anesthetized rabbits. Am J Cardiol (1987) 0.89
Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells. FEBS Lett (1998) 0.89
Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells. Biochem J (1987) 0.87
Modulation by prednisolone of calcium handling in skeletal muscle cells. Br J Pharmacol (1995) 0.87
Increase of empty pool-activated Ca2+ influx using an intracellular Ca2+ chelating agent. Biochem Biophys Res Commun (1996) 0.87
PY 108-068, a new, potent, and selective inhibitor of calcium-induced contraction of rabbit aortic rings. J Cardiovasc Pharmacol (1982) 0.87
Proceedings: The effect of PGE1, PGE2 and PGF2alpha on parasympathetic transmission. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.86
Sprouting and nerve retraction in frog neuromuscular junction during ontogenesis and environmental changes. Neuroscience (1986) 0.86
Contribution of donor-specific antibodies to acute allograft rejection: evidence from B cell-deficient mice. Transplantation (1998) 0.86
Stereoselectivity at the calcium channel: different profiles of hemodynamic activity of the enantiomers of the dihydropyridine derivative PN 200-110. J Cardiovasc Pharmacol (1986) 0.86
Differential blockade of agonist- and depolarization-induced 45Ca2+ influx in smooth muscle cells. Am J Physiol (1989) 0.86
Acceleration of blood in the aorta: a parameter useful for evaluating cardiotonic and afterload reducing substances. J Pharmacol Methods (1981) 0.85
Alkylation of cysteine thiols with 1,3-propane sultone. Methods Enzymol (1977) 0.85
Serotonin increases the production of inositol phosphates and mobilises calcium via the 5-HT2 receptor in A7r5 smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.85
Very small microspheres are useful for the determination of cardiac output but not organ blood flow in conscious rabbits. Experientia (1981) 0.85
Pharmacological actions of APP 201-533, a novel cardiotonic agent. J Cardiovasc Pharmacol (1985) 0.84
[Bicyclic 3-hydrazinopyridazines with antihypertensive action (author's transl)]. Arzneimittelforschung (1979) 0.84
A simple cutter for fresh tissue to facilitate the investigation of intramyocardial blood flow with tracer microspheres in cats and rabbits. J Pharmacol Methods (1982) 0.83
Cyclosporin A potentiates receptor-activated [Ca2+]c increase. J Recept Signal Transduct Res (1997) 0.83
PY 108-068: a calcium antagonist with an unusual pattern of cardiovascular activity. Gen Pharmacol (1985) 0.83
Reaction of cysteine thiol groups with 1,3-propane sultone: S-3-sulphopropyl as a modifying group for protein chemistry. Int J Pept Protein Res (1974) 0.82
Herpes zoster in breast cancer patients after radiotherapy. Strahlenther Onkol (2000) 0.82
The calcium antagonists PY 108-068 and verapamil diminish the effects of angiotensin II: sites of interaction in the peripheral circulation of anaesthetized cats. Br J Pharmacol (1984) 0.82
Effects of bromocriptine on the heart and the peripheral circulation of anesthetized cats. J Cardiovasc Pharmacol (1984) 0.81
Interaction of DPI 201-106 with cardiac glycosides. J Cardiovasc Pharmacol (1989) 0.81
Cardiovascular actions of DPI 201-106, a novel cardiotonic agent. J Cardiovasc Pharmacol (1986) 0.81
A smooth muscle cell line suitable for the study of voltage sensitive calcium channels. Biochem Biophys Res Commun (1985) 0.81
Selective effects of PN 200-110 (isradipine) on the peripheral circulation and the heart. Am J Cardiol (1987) 0.81
Reduction of S-sulpho groups by tributylphosphine: an improved method for the recombination of insulin chains. Hoppe Seylers Z Physiol Chem (1975) 0.80
Vasopressin increases 45Ca2+ influx in rat aortic smooth muscle cells. Biochem Biophys Res Commun (1987) 0.80
Mechanism of enhanced vasoconstrictor hormone action in vascular smooth muscle cells by cyclosporin A. Br J Pharmacol (1997) 0.80
Purification and chemical characterization of melittin and acetylated derivatives. Biochim Biophys Acta (1980) 0.80
Biphasic effects of cyclosporin A on formyl-methionyl-leucyl-phenylalanine stimulated responses in HL-60 cells differentiated into neutrophils. Br J Pharmacol (1998) 0.80
Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models. Transpl Immunol (2001) 0.80
Prevention of graft vessel disease by combined FTY720/cyclosporine. A treatment in a rat carotid artery transplantation model. Transplantation (2000) 0.79
4-pyridylmethyl, a thiol-protecting group suitable for the partial synthesis of proteins. Biochem J (1979) 0.79
Modulation of electrical activity and of intracellular calcium oscillations of smooth muscle cells by calcium antagonists, agonists, and vasopressin. J Cardiovasc Pharmacol (1991) 0.79
Correlation between substance P content of primary sensory neurones and pain sensitivity in rats exposed to antibodies to nerve growth factor. Eur J Pharmacol (1982) 0.79
[Pharmacologic effects of the antihypertensive 6-benzoyl-3-hydrazino-5,6,7,8-tetrahydropyrido[4,3-c]pyridazine (BQ 22-708, endralazine)]. Arzneimittelforschung (1979) 0.79
The role of magnetic resonance imaging and spectroscopy in transplantation: from animal models to man. NMR Biomed (2000) 0.79
Effect of spirapril on left ventricular hypertrophy due to volume overload in rats. J Cardiovasc Pharmacol (1992) 0.79
Cerebrovascular, biochemical, and cytoprotective effects of isradipine in laboratory animals. Am J Med (1989) 0.79
Coronary ligation-reperfusion arrhythmia models in anesthetized rats and isolated perfused rat hearts concentration-effect relationships of lidocaine. J Pharmacol Methods (1986) 0.79
Spirapril and cilazapril inhibit neointimal lesion development but cause no detectable inhibition of lumen narrowing after carotid artery balloon catheter injury in the rat. Blood Press (1993) 0.78
Time course of spirapril-induced structural and functional changes after myocardial infarction in rats followed with magnetic resonance imaging. J Cardiovasc Pharmacol (1993) 0.78
Interaction between two calcium antagonists and two beta blockers in conscious rabbits: hemodynamic consequences of differing cardiodepressant properties. Am J Cardiol (1987) 0.78
Effects of the enantiomers of the dihydropyridine derivative 202-791 on contractility, coronary flow and ischemia-related arrhythmias in rat heart. Eur J Pharmacol (1986) 0.78
Studies on capacitative calcium entry in vascular smooth muscle cells by measuring 45CA2+ influx. J Recept Signal Transduct Res (1997) 0.78
Digoxin-specific antibody fragments and a calcium antagonist for reversal of digoxin-induced mesenteric vasoconstriction. J Pharm Pharmacol (1983) 0.77
Metabolism-dependent stimulation of reactive oxygen species and DNA synthesis by cyclosporin A in rat smooth muscle cells. Free Radic Biol Med (1999) 0.77
[Radiation-induced morphea]. Hautarzt (1999) 0.77
Combined FTY720/cyclosporine treatment promotes graft survival and lowers the peripheral lymphocyte count in a murine cardiac allotransplantation model. Transplantation (2001) 0.77
Proarrhythmic effects of DPI 201-106 elicited with programmed electrical stimulation: a comparison with sotalol. J Cardiovasc Pharmacol (1993) 0.77
The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD. Transpl Immunol (2000) 0.77
PY 108-068, a dihydropyridine derivative, and verapamil interact differently with the ouabain effects on the heart and the peripheral circulation. Basic Res Cardiol (1985) 0.77
Antivasoconstrictor effects of isradipine. A quantitative approach in anesthetized rats and conscious rabbits. Am J Med (1989) 0.76
The effects of treatment and of withdrawal of treatment with guanfacine and clonidine on blood pressure and heart rate in normotensive and renal hypertensive rats. J Pharm Pharmacol (1979) 0.76
Reductive cleavage of S-sulfo groups with tributylphosphine. Methods Enzymol (1977) 0.76